A decrease of 830 cases in active Covid-19 burden has been recorded within 24 hours and more than 136 crores of vaccine doses have been administered so far under the nationwide vaccination campaign. But that achievement appears to have been overshadowed by the growing number of Omicron cases in the country.

Corona Virus Vaccine Registration, Variable Cases of Corona Virus Omicron in India, Live Updates: India recorded a total of 7,145 new cases of Covid-19 and 289 deaths in the past 24 hours, according to data released by the Federal Ministry of Health on Saturday morning. The data also highlighted that a total of 8,706 recoveries were made in the last 24 hours bringing the total number of recovery victims to 3,41,71,471. The recovery rate is currently 98.38% which is the highest since March 2020.

The number of active cases in India is 84,565, the lowest in 569 days. A decrease of 830 in the number of active cases of Covid-19 was recorded within 24 hours. More than 136 crore doses of vaccine have also been administered so far as part of the nationwide vaccination campaign. But that achievement appears to have been overshadowed by the growing number of Omicron cases in the country.

In a weekly press briefing on Friday, Lav Agrawal, joint secretary at the Ministry of Health, highlighted the growing global threat of Omicron cases and urged people to avoid non-essential travel. Agrawal said India has so far reported 101 cases of the Omicron variant across 11 states. The ministry also cited the rapid spread of Omicron, which is a major cause for government concern. “Omicron is spreading faster than the delta variant in South Africa, where delta circulation has been low. It also appears to be spreading more quickly than delta in places where delta prevalence is high, such as the UK,” Agrawal said.

The ministry is warning people to avoid mass gatherings, especially around the new year due to the high number of Omicron cases, and the warning was lifted again on Friday by Dr Balram Bhargava, Director General of ICMR. “This is the time to avoid non-essential travel, mass gatherings and it is very important to observe low intensity celebrations (Christmas, New Year),” said Bhargava.

In another global development, the World Health Organization has released an emergency use list for Covovax, an anti-Covid vaccine being produced by the Serum Institute of India (SII) based in Pune under license from Novavax. SII CEO Adar Poonawalla said: “This is another milestone in our fight against Covid-19, Covovax is now WHO approved for emergency use, demonstrating excellent safety and efficacy.”

Financial Express Online brings you the latest updates on the coronavirus pandemic. stay tuned

Source link

By admin

Leave a Reply

Your email address will not be published.